NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity
Abstract. Studies support a role for natural killer (NK) cells in cancer control, making these cells attractive for immunotherapy. One method being tested